Do not combine AFINITOR and AFINITOR DISPERZ to achieve the total daily dose.
Modify the dose for patients with hepatic impairment or for patients taking drugs that inhibit or induce P-glycoprotein (P-gp) and CYP3A4.
Breast Cancer:
NET:
RCC:
TSC-Associated Renal Angiomyolipoma:
TSC-Associated SEGA:
TSC-Associated Partial-Onset Seizures: